Advertisement

Tissue Characterization in Brain Lesions: A Review of the State of the Art

  • H. P. Higer
  • M. Brant-Zawadzki
Conference paper

Abstract

Relaxation processes observed with magnetic resonance imaging (MRI) originate from magnetic interactions between protons and their biochemical environment. The MR tissue parameters (T1, T2, and proton density, PD) are true physical characteristics of biological tissues but do not necessarily directly express histochemical arrangements.

Keywords

Tissue Characterization Nuclear Magnetic Resonance Tomography Tissue Parameter Choroid Plexus Papilloma Paramagnetic Contrast Agent 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Atlas SW, Grossman RI, Gomori JM, Hachney DB, Goldberg HI, Zimmerman RA, Bilaniuk LT (1987) Hemorrhagic intracranial malignant neoplasms. Radiology 164:71–76PubMedGoogle Scholar
  2. 2.
    Barloon TJ, Yuh WT, Yang CJ, Schultz DH (1987) Spinal subarachnoid tumor seeding from intracranial metastases: MR findings. J Comput Assist Tomogr 11, 2:242–244PubMedCrossRefGoogle Scholar
  3. 3.
    Bottomley PA, Hardy CJ, Argersinger RE, Allen-Moore G (1987) A review of 1H nuclear magnetic resonance relaxation in pathology: Are T1 and T2 diagnostic? Med Phys 14, 1:1–37PubMedCrossRefGoogle Scholar
  4. 4.
    Brant-Zawadzki M, Norman D, Newton TH, Kelly WM, Kjos BO, Mills CM, Sobel D, Crooks LE (1984) Magnetic resonance of the brain: the optimal screening technique. Radiology 152:71–77PubMedGoogle Scholar
  5. 5.
    Breger RK, Papke RA, Pojunas KW, Haughton VM, Wiliams AL, Daniels DL (1987) Benign extraaxial tumors: contrast enhancement with Gd-DTPA. Radiology 163, 2:427–429PubMedGoogle Scholar
  6. 6.
    Chatel M, Darcel F, de Certaines J, Benoist L, Bernard AM (1986) T1 and T2 proton nuclear magnetic resonance relaxation times in vitro and human intracranial tumours. Results from 98 patients. J Neurooncol 3, 4:315–321PubMedCrossRefGoogle Scholar
  7. 7.
    Darwin RH, Drayer BP, Riederer SJ, Wang HZ, MacFall JR (1986) T2 estimates in healthy and diseased brain tissue: a comparison using various MR pulse sequences. Radiology 160, 2:375–381PubMedGoogle Scholar
  8. 8.
    Earnest FIV, Kelly PJ, Scheithauer BW, Kail BA, Cascino TL, Ehman RL, Forbes GS, Axley PL (1988) Cerebral astrocytomas: Histopathologic correlation of MR and CT contrast enhancement with stereotactic biopsy. Radiology 166:823–827PubMedGoogle Scholar
  9. 9.
    Englund E, Brun A, Larsson EM, Gyroffy-Wagner Z, Persson B (1986) Tumours of the central nervous system. Proton magnetic resonance relaxation times T1 and T2 and histopathologic correlates. Acta Radiol 27, 6:653–659Google Scholar
  10. 10.
    Goldstein S, Neuwelt EA (1987) Superior sensitivity of computed tomographic scanning to magnetic resonance imaging in metastatic neoplasia: two case reports. Neurosurgery. 20, 6:959–962PubMedCrossRefGoogle Scholar
  11. 11.
    Healy ME, Hesselink JR, Press GA, Middleton MS (1987) Increased detection of intracranial metastases with intravenous Gd-DTPA. Radiology 165:619–624PubMedGoogle Scholar
  12. 12.
    Haughton VM, Rimm AA, Czervionke LF, Breger RK, Fisher ME, Papke RA, Hendrix LE, Strother CS, Turski PA, Williams AL, Daniels DL (1988) Sensitivity of GD-enhanced MR imaging of benign extraaxial tumors. Radiology 166:829–833PubMedGoogle Scholar
  13. 13.
    Higer HP, Gutjahr P, Schmidberger P, Dittrich M, Pfannenstiel P (1985) NMR investigation of the central nervous system in paediatrics. Fortschr Röntgenstr 143, 2:137–145CrossRefGoogle Scholar
  14. 14.
    Higer HP, Bielke G (1986) Tissue characterization with T1, T2 and proton density -dream and reality. Fortschr Röntgenstr 144, 5:597–605CrossRefGoogle Scholar
  15. 15.
    Higer HP, Dittrich M, Just M, Gutjahr P, Schwarz M, Pfannenstiel P (1987) Long-term studies of children following therapy of brain tumors using nuclear magnetic resonance tomography and ultrasound. Monatsschr Kinderheilkd 135, 3:161–165PubMedGoogle Scholar
  16. 16.
    Higer HP, Just M, Grigat M, Meindl S, Jungke M, Bielke G, Pedrosa P, Kunze S, Voth D (1988) Gadolinium-dimeglumin-gadopentetate compared with CPMG sequence and image synthesis. Fortschr Röntgenstr 148, 3:307–313CrossRefGoogle Scholar
  17. 17.
    Higer HP (1989) Paramagnetic contrast agents, synthetic images and the CPMG-sequence: a comparison. In: Rinck PA, (ed) Contrast and contrast agents in magnetic resonance imaging. MonsGoogle Scholar
  18. 18.
    Higer HP, Just M (eds) (1989) Atlas der Hirntumore. Thieme, Stuttgart New YorkGoogle Scholar
  19. 19.
    Higer HP, Pedrosa P, Schaeben W, Bielke G, Meindl S (1989) Intracranial bleeding in MRI. Radiologe 29:297–302PubMedGoogle Scholar
  20. 20.
    Jungke M, von Seelen W, Bielke G, Meindl S, Grigat M, Pfannenstiel P (1988) A system for the diagnostic use of tissue characterizing parameters in NMR-imaging. In: Viergever M, De Graaf CN, (eds) Information processing in medical imaging. New YorkGoogle Scholar
  21. 21.
    Just M, Higer HP, Vahldiek G, Bohl J, Schwarz M, Kunze S, Pfannenstiel P (1987) MR-Tomographic bei Glioblastomen und zerebralen Metastasen. Radiologe 27:473–478PubMedGoogle Scholar
  22. 22.
    Just M, Higer HP, Vahldiek G, Bohl J, Kunze S, Hey O, Pfannenstiel P (1987) MR imaging of benign brain tumours. Fortschr Röntgenstr 147, 4:386–392CrossRefGoogle Scholar
  23. 23.
    Just M, Higer HP, Schwarz M, Bohl J, Fries G, Pfannenstiel P, Thelen M (1988) Tissue characerization of benign tumors: use of NMR-tissue parameters. Magn Reson Imaging 6:463–472PubMedCrossRefGoogle Scholar
  24. 24.
    Just M, Thelen M (1988) Tissue characterization with T1, T2 and proton Density values: results in 160 patients with brain tumors. Radiology 169:779–785PubMedGoogle Scholar
  25. 25.
    Kelly PJ, Daumas-Duport C, Kispert DB, Kail BA, Scheithauer BW, Illig J J (1987) Imaging based stereotaxic serial biopsies in untreated intracranial glial neoplasms. J Neurosurg 66, 6:865–874PubMedCrossRefGoogle Scholar
  26. 26.
    Kiricuta I Jr, Simplaceau V (1975) Tissue water content and nuclear magnetic resonance in normal and tumor tissues. Cancer Res 35:1164–1167PubMedGoogle Scholar
  27. 27.
    Komiyama M, Yagura H, Baba M, Yasui T, Hakuba A, Nishimura S, Inoue Y (1987) MR imaging: possibility of tissue characterization of brain tumors using T1 and T2 values. AJNR 8, 1:65–70PubMedGoogle Scholar
  28. 28.
    Koschorek F, Jensen HP, Terwey B (1987) Dynamic MR imaging: a further possibility for characterizing CNS lesions. AJNR 8, 2:259–262PubMedGoogle Scholar
  29. 29.
    Mamourian AC, Towfighi J (1986) Pineal cysts: MR imaging. AJNR 7:1081–1086PubMedGoogle Scholar
  30. 30.
    Pedrosa P, Pfannenstiel P, Just M, Higer HP, Utech C, Brederhoff J, Wulle KG (1988) Results of magnetic resonance imaging in endocrine orbitopathy. Klin Monatsbl Augen-heilkd 193:169–173CrossRefGoogle Scholar
  31. 31.
    Pedrosa P, Grigat M, Higer HP, Straube U, Schaeben W, Gutjahr P, Voth D, Kunze S (1989) MR tomography in astrocytic tumors (I—III). Fortschr Röntgenstr 150, 1:52–57CrossRefGoogle Scholar
  32. 32.
    Rinck PA, Meindl S, Higer HP, Bieler EU, Pfannenstiel P (1985) Brain tumors: detection and typing by use of CPMG sequences and in vivo T2 measurements. Radiology 157:103–107PubMedGoogle Scholar
  33. 33.
    Russel EJ, Geremia GK, Johnson CE, Huckman MS, Ramsey RG, Washburn-Bleck J, Turner DA, Norusis M (1987) Multiple cerebral metastases: detectability with Gd-DTPA-enhanced MR imaging. Radiology 165:609–617Google Scholar
  34. 34.
    Schörner W, Laniado M, Niendorf HP, Schubert C, Felix R (1986) Time-dependent changes in image contrast in brain tumors after gradolinium-DTPA. AJNR 7, 6:1013–1020PubMedGoogle Scholar
  35. 35.
    Skalej M, Higer HP, Meves M, Brueckner A, Bielke G, Meindl S, Rinck PA, Pfannenstiel P (1985) T2-analysis of normal and pathological structures of the head. Digit Bilddiagn 5:112–119Google Scholar
  36. 36.
    Sze G, Krol G, Olsen WL, Harper PS, Galicich JH, Heier LA, Zimmerman RD, Deck MDF (1987) Hemorrhagic neoplasms: MR mimics of occult vascular malformations. AJNR 8:795–781Google Scholar
  37. 37.
    Seiler T, Bende T, Schilling A, Wollensak J (1987) Magnetic resonance tomograhy in ophthalmology. I: Choroidal melanoma. Klin Monatsbl Augenheilkd 191:203–210PubMedCrossRefGoogle Scholar
  38. 38.
    Thömke F, Just M, Bohl J, Hopf HC (1988) Cerebral melanoma metastases - comparison of MR imaging and histopathological study. Aktuel Neurol 15, 5:152–155CrossRefGoogle Scholar
  39. 39.
    Treisch J, Schörner W, Laniado M, Felix R (1987) Characteristics of intracranial meningeoma imaged by magnetic resonane tomography. Fortschr Röntgenstr 146, 2:207–214CrossRefGoogle Scholar
  40. 40.
    Weiss T, Mitsch E, Laniado M, Sander B, Kornmesser W, Deimling M, Felix R (1987) Rapid nuclear magnetic resonance tomography. Initial results of studies using the new gradient echo sequence. Fortschr Röntgenstr 146, 2:214–222CrossRefGoogle Scholar
  41. 41.
    Welton PL, Reicher MA, Kellerhouse LE, Ott KH (1988) MR of benign pineal cyst. AJNR 9:612PubMedGoogle Scholar
  42. 42.
    Woodruff WW, Djano WT, McLendon RE, Heinz ER, Voorhees DR (1987) Intracerebral malignant melanoma: high-field-strength MR imaging. Radiology 165, 1:209–213PubMedGoogle Scholar
  43. 43.
    Yoshida K, Inao S, Saso K, Motegi Y, Kaneoke Y, Furuse M (1987) Evaluation of peritumoral edema by proton T1 values with special remarks on time courses following intracranial surgery (abstract in english). No Shinkei Geka 15, 4:389–395PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • H. P. Higer
    • 1
  • M. Brant-Zawadzki
  1. 1.MRI DepartmentDeutsche Klinik für DiagnostikWiesbadenGermany

Personalised recommendations